ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,429Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 300

$578K Total Retail Price of All Prescriptions

Rank: 30 out of 300

428 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
9% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 428 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 7,685 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $81 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 447 416 1 9
CRESTOR 415 382 2 26
PREDNISONE 271 255 3 33
LOSARTAN POTASSIUM 255 233 4 29
NEXIUM 237 203 5 17
FUROSEMIDE 227 200 6 3
METOPROLOL TARTRATE 210 206 7 13
BYSTOLIC 205 167 8 59
SIMVASTATIN 185 178 9 5
LOVASTATIN 175 159 10 68
WARFARIN SODIUM 171 154 11 10
POTASSIUM CHLORIDE 151 130 12 22
METFORMIN HCL 150 150 13 19
AMLODIPINE BESYLATE 134 131 14 2
PRAVASTATIN SODIUM 128 119 15 15
HYDROCODONE-ACETAMINOPHEN 127 121 S3 16 1
GABAPENTIN 111 107 17 7
HYDROCHLOROTHIAZIDE 103 78 18 20
SYNTHROID 98 83 19 49
METOPROLOL SUCCINATE 97 97 20 6
SERTRALINE HCL 97 96 20 41
CAPTOPRIL 89 72 22 270
OMEPRAZOLE 85 83 23 11
CLONIDINE HCL 78 75 24 50
CYMBALTA 74 64 25 37
CALCITONIN-SALMON 73 72 26 294
VYTORIN 72 67 27 154
PRADAXA 72 72 27 108
TEKTURNA 71 65 29 384
AVAPRO 67 64 30 392
LISINOPRIL 66 64 31 4
JANUVIA 66 64 31 100
IRBESARTAN 63 50 33 344
ZOLPIDEM TARTRATE 63 56 33 21
ISOSORBIDE MONONITRATE ER 62 61 35 32
ALLOPURINOL 62 50 35 44
BUMETANIDE 62 60 35 126
CIPROFLOXACIN HCL 62 59 35 28
AZITHROMYCIN 61 54 39 72
TRIAMTERENE-HCTZ 60 49 40 118
CITALOPRAM HBR 59 45 41 54
INDAPAMIDE 56 56 42 420
ATORVASTATIN CALCIUM 55 42 43 14
VERAPAMIL ER 53 45 44 113
NAMENDA 53 53 44 48
GUANFACINE HCL 52 52 R 46 436
LANTUS SOLOSTAR 52 38 46 212
LANTUS 51 44 48 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 7, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.